Company profile
America Great Health
OTC: AAGH · Healthcare · Biotechnology
#952 of 1,418 Healthcare companies by revenue73rd-percentile growth
EA Score
39DFH 33DQ 42GM 54SS 39
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, disclosure history · ↓ filing timeliness, balance-sheet leverage
Methodology →Revenue TTM
$363.3k
Rev growth YoY (TTM)
-5.1%
Net income (FY)
-$719.1k
Employees
5
as of 2026-08-25
Market cap
$4.2M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$391.7k$391.7k2025
Net income-$719.1k-$719.1k2025
Operating income-$382.9k-$382.9k2025
Total assets$301.8k$301.8k2025
Liabilities$6.0M$6.0M2025
Equity-$5.7M-$5.7M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is America Great Health’s revenue?
America Great Health booked $391.7k in FY2025 revenue, growing 33% year over year — faster than most Healthcare companies we track, at a -183.6% net margin.
Peers · Healthcare
Neurogenesis, Inc.——Lyra Therapeutics, Inc.30DOMID Holdings, Inc.48DOMNI Health, Inc.——BioRestorative Therapies, Inc.38DHealth Sciences Group, Inc.——Neighbors
Los Angeles →Key facts
CEOMike Qingkun Wang
SectorHealthcare
IndustryBiotechnology
HeadquartersAlhambra, CA
ExchangeOTC: AAGH
Employees5
IPO date2012-09-25
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.